| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0013300 | Exon-Exon | chr6:146264722-146266549 | chr6:145943586-145945413 | 33 nt | 0.3030 |
| hsa_SHPRH_0013400 | Intron-Exon | chr6:146266486-146268703 | chr6:145945350-145947567 | 472 nt | 0.3708 |
| hsa_SHPRH_0013600 | Exon-Exon | chr6:146266517-146273614 | chr6:145945381-145952478 | 1078 nt | 0.4156 |
| hsa_SHPRH_0013700 | Exon-Exon | chr6:146267369-146275989 | chr6:145946233-145954853 | 985 nt | 0.4223 |
| hsa_SHPRH_0013800 | Exon-Exon | chr6:146268629-146271618 | chr6:145947493-145950482 | 151 nt | 0.4768 |
| hsa_SHPRH_0013900 | Intron-Exon-Intron | chr6:146268629-146273059 | chr6:145947493-145951923 | 582 nt | 0.4725 |
| hsa_SHPRH_0014000 | Exon-Exon | chr6:146268629-146273614 | chr6:145947493-145952478 | 712 nt | 0.4480 |
| hsa_SHPRH_0014100 | Exon-Exon | chr6:146271400-146275989 | chr6:145950264-145954853 | 164 nt | 0.3720 |
| hsa_SHPRH_0014200 | Exon-Exon | chr6:146271400-146276490 | chr6:145950264-145955354 | 219 nt | 0.4749 |
| hsa_SHPRH_0014300 | Exon-Exon | chr6:146273485-146276490 | chr6:145952349-145955354 | 130 nt | 0.3385 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].